Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer.

Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer.

Item
http://www.wikidata.org/entity/Q38145803
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey.Management of menopausal symptoms for breast cancer patients.Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer.Altered regulation of PDK4 expression promotes antiestrogen resistance in human breast cancer cellsThe impact of Anastrazole and Letrozole on the metabolic profile in an experimental animal model.The changing role of ER in endocrine resistance.Characterizing and quantifying the effects of breast cancer therapy using mathematical modeling.The UZ Leuven Policy for Extended Adjuvant Anti-estrogen Therapy in Women With Early Estrogen Receptor-Positive Breast Cancer.
P2860

Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer.

Item
http://www.wikidata.org/entity/Q38145803
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer.
@en
type
label
Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer.
@en
prefLabel
Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P478
P50
P577
P698
P356
P1433
P1476
Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer.
@en
P2093
P304
P31
P356
10.1016/J.BREAST.2013.07.033
P478
P50
P577
P698